Spots Global Cancer Trial Database for therapeutic drug monitoring
Every month we try and update this database with for therapeutic drug monitoring cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
| Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study | NCT05362630 | Graft Versus Ho... Hematopoietic S... | - 18 Years | University of Pisa | ||
| Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study | NCT05362630 | Graft Versus Ho... Hematopoietic S... | - 18 Years | University of Pisa | ||
| Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics | NCT04678089 | Multiple Myelom... Bortezomib | Bortezomib | 18 Years - 100 Years | Beijing Chao Yang Hospital | |
| Exploratory Drug Interaction Study Between SMIs and DOACs | NCT05732350 | Solid Tumor Cancer, Lung | 18 Years - | Maastricht University Medical Center | ||
| Ponatinib in CML Patients in Chronic Phase | NCT06119269 | Chronic Myeloid... | Therapeutic dru... Molecular Respo... | 18 Years - | University of Pisa | |
| Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer | NCT05830279 | Nausea With Vom... Depression, Rea... Cancer Pain | Pharmacogenetic... Drug-Drug inter... | 18 Years - | Lawson Health Research Institute | |
| Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia | NCT05259228 | Tyrosine Kinase... Pharmacokinetic... Therapeutic Dru... | 20 Years - | National Taiwan University Hospital | ||
| Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics | NCT04678089 | Multiple Myelom... Bortezomib | Bortezomib | 18 Years - 100 Years | Beijing Chao Yang Hospital | |
| Ponatinib in CML Patients in Chronic Phase | NCT06119269 | Chronic Myeloid... | Therapeutic dru... Molecular Respo... | 18 Years - | University of Pisa | |
| A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing | NCT01416025 | Fungal Infectio... | Prospective TDM... | 12 Years - 100 Years | Johns Hopkins University | |
| Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
| Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy | NCT01148160 | Invasive Fungal... | voriconazole | 15 Years - | Asan Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
